Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDiBio Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.07 | -$0.04 | -$0.06 |
| Q2 2026 | 5 | -$0.08 | -$0.04 | -$0.06 |
| Q3 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q1 2027 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2027 | 1 | -$0.08 | -$0.08 | -$0.08 |
iBio Inc Earnings Date And Information
iBio Inc last posted its earnings results on Tuesday, February 10th, 2026. The company reported $-0.09 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0.01. The company had revenue of 0 for the quarter and had revenue of 400.00 K for the year. iBio Inc has generated $-2 earnings per share over the last year ($-1.75 diluted earnings per share) and currently has a price-to-earnings ratio of -6.72. iBio Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
iBio Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q3 2026 | N/A | -$0.06 | N/A | $20.00 K | $0 |
| 02/10/2026 | Q2 2026 | -$0.08 | -$0.09 | -0.01 | $50.00 K | $0 |
| 11/12/2025 | Q1 2026 | -$0.07 | -$0.11 | -0.04 | $33.33 K | $100.00 K |
| 09/05/2025 | Q4 2025 | -$0.39 | -$0.31 | 0.08 | $100.00 K | $200.00 K |
| 05/02/2025 | Q3 2025 | -$0.39 | -$0.49 | -0.1 | $100.00 K | $0 |
| 02/10/2025 | Q2 2025 | -$0.45 | -$0.48 | -0.03 | $100.00 K | $200.00 K |
| 11/12/2024 | Q1 2025 | -$0.46 | -$0.46 | 0 | N/A | $0 |
| 09/20/2024 | Q4 2024 | N/A | -$0.90 | N/A | N/A | $175.00 K |
| 05/13/2024 | Q3 2024 | N/A | -$0.85 | N/A | N/A | $0 |
| 02/09/2024 | Q2 2024 | N/A | -$4.42 | N/A | N/A | $0 |
| 09/29/2023 | Q1 2024 | N/A | -$4.79 | N/A | N/A | $50.00 K |
| 09/27/2023 | Q4 2023 | -$0.41 | -$5.94 | -5.53 | N/A | $0 |
| 05/15/2023 | Q3 2023 | N/A | -$11.06 | N/A | N/A | $0 |
| 02/14/2023 | Q2 2023 | -$146.90 | -$68.43 | 78.47 | N/A | $0 |
| 11/14/2022 | Q1 2023 | -$1.85 | -$41.01 | -39.16 | N/A | $0 |
| 10/11/2022 | Q4 2022 | -$2.12 | -$977.06 | -974.94 | N/A | $61.00 K |
| 05/12/2022 | Q3 2022 | -$1.25 | -$28.42 | -27.17 | N/A | $1.80 M |
| 02/14/2022 | Q2 2022 | -$1.00 | -$27.39 | -26.39 | N/A | $0 |
| 11/15/2021 | Q1 2022 | -$1.25 | -$20.66 | -19.41 | N/A | $84.00 K |
| 09/28/2021 | Q4 2021 | N/A | $0.12 | N/A | N/A | $491.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
iBio Inc Earnings: FAQ's
The conference call for iBio Inc's latest earnings report can be listened to online.
The conference call transcript for iBio Inc's latest earnings report can be read online.
iBio Inc (:IBIO) has a recorded annual revenue of $400.00 K.
iBio Inc (:IBIO) has a recorded net income of $-18,377,000.iBio Inc has generated $-1.75 earnings per share over the last four quarters.
iBio Inc (:IBIO) has a price-to-earnings ratio of -6.72 and price/earnings-to-growth ratio is -0.04.